Hydrocephalus epidemiology and demographics

Revision as of 05:06, 22 July 2012 by Kalsang Dolma (talk | contribs) (Created page with "{{Hydrocephalus}} {{CMG}}; '''Associate Editor-In-Chief:''' Cafer Zorkun M.D., PhD.,Kalsang Dolma, MBBS == Epidemiology and Demographics== Hydrocephalus affect...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Hydrocephalus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Electrocardiogram

X-ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hydrocephalus epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hydrocephalus epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Hydrocephalus epidemiology and demographics

CDC on Hydrocephalus epidemiology and demographics

Hydrocephalus epidemiology and demographics in the news

Blogs onHydrocephalus epidemiology and demographics

Directions to Hospitals Treating Hydrocephalus

Risk calculators and risk factors for Hydrocephalus epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun M.D., PhD.,Kalsang Dolma, MBBS

Epidemiology and Demographics

Hydrocephalus affects one in every 500 live births, making it one of the most common birth defects, more common than Down syndrome or deafness. There are an estimated 700,000 children and adults living with hydrocephalus, and it is the leading cause of brain surgery for children in the United States.

Overview

(insert disease state here) is a major health problem affecting _____ patients in the United States and ____ patients worldwide.

or

(insert disease state here) is a common health problem affecting _____ patients in the United States and ____ patients worldwide.

or

(insert disease state here) is a common health problem that tends to more often affect the ____ (elderly for example) and _____ (men for example).

or

(insert disease state here) is a rare disease (defined as a prevalence of < 50 per 100,000 patients or < 200,000 patients affected in the United States) with a prevalence of ______ per 100,000 patients.

Prevalence

Worldwide, the prevalence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average prevalence of _____ per 100,000 patients.

Worldwide, the prevalence of (insert disease state here) is _____ per 100,000 patients.

In developed countries, the prevalence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average prevalence of _____ per 100,000 patients.

In developed countries, the prevalence of (insert disease state here) is _____ per 100,000 patients.

In developing countries, the prevalence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average prevalence of _____ per 100,000 patients.

In developing countries, the prevalence of (insert disease state here) is _____ per 100,000 patients.

In Africa, the prevalence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average prevalence of _____ per 100,000 patients.

In Africa, the prevalence of (insert disease state here) is _____ per 100,000 patients.

Incidence

Worldwide, the incidence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average incidence of _____ per 100,000 patients.

Worldwide, the incidence of (insert disease state here) is _____ per 100,000 patients.

In developed countries, the incidence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average incidence of _____ per 100,000 patients.

In developed countries, the incidence of (insert disease state here) is _____ per 100,000 patients.

In developing countries, the incidence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average incidence of _____ per 100,000 patients.

In developing countries, the incidence of (insert disease state here) is _____ per 100,000 patients.

In Africa, the incidence of (insert disease state here) ranges from a low of _____ per 100,000 patients, to a high of _____ per 100,000 patients with an average incidence of _____ per 100,000 patients.

In Africa, the incidence of (insert disease state here) is _____ per 100,000 patients.

Age

The prevalence of (insert disease state here) increases with age.

Gender

(insert disease state here) is more common in males females. The prevalence of (insert disease state here) among men is ____ per 100,000, while it is _____ per 100,000 among women. The incidence of (insert disease state here) among men is ____ per 100,000, while it is _____ per 100,000 among women.

or

Gender is not associated with an increased risk of (insert disease state here)

Race

Race is not associated with an increased risk of (insert disease state here)

References

Template:WH Template:WS